Home›Stock Screener›Transgene Biotek›P/E Ratio

Transgene Biotek P/E Ratio

Transgene Biotek P/E ratio. Transgene Biotek (TRABI) P/E ratio is not applicable — EPS (TTM) ₹-0.22, 8 consecutive loss quarters. See Healthcare Services peers with valid P/E ratios below.

P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable

Company has been reporting losses for 8 consecutive quarters. P/E ratio cannot be calculated for loss-making companies.

Consecutive Loss Quarters: 8

Current EPS: ₹-0.22

Recent Quarterly Performance

Quarter EPS (₹) Net Profit (₹ Cr) Status
Mar 2026 -0.06 -1 Loss
Jun 2026 -0.05 0 Loss
Sept 2025 -0.05 0 Loss
Mar 2025 -0.09 -1 Loss
Jun 2025 -0.06 0 Loss
Dec 2025 -0.05 0 Loss
Sept 2024 -0.01 0 Loss
Mar 2024 -0.04 0 Loss

Healthcare Services Peers with Valid P/E Ratios — TRABI Comparison

Healthcare Services sector average P/E 94.34, median 44.39 — TRABI excluded (negative EPS).

Sector Average PE
94.34
Sector Median PE
44.39
Lowest PE
6.97
Profitable Companies
58
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Star Imaging And Path Lab STARIMAGIN 6.97 ₹131 Low
Abate AS Industries ABATEAS 10.23 ₹122 Low
Deccan Health Care DECCAN 11.37 ₹29 Low
Nidan Labs & Healthcare NIDAN 11.94 ₹17 Low
One Global Service Provi… ONEGLOBAL 13.97 ₹1,027 Low
Shanmuga Hospital SHANMUGA 14.42 ₹61 Low
Indraprastha Medical Cor… INDRAMEDCO 16.52 ₹3,061 Moderate
Invicta Diagnostic INVICTA 17.24 ₹85 Moderate
Krsnaa Diagnostics KRSNAA 17.83 ₹1,796 Moderate
Dhanvantri Jeevan Rekha ZDHJERK 18.19 ₹9 Moderate

Related Analysis